Explore compound GLP3-R$280.00
Skip to content
RESEARCH, REFINED.
The details
Considered compounds. Documented standards.Explore our standard
RESEARCH, REFINED.Metabolic research
GLP2-T
20 mg / $150.00
GLP2-T is the house designation for a synthetic, acylated dual-agonist peptide of the incretin family — one engineered sequence that engages two receptor pathways at once: the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor.
1
Availability and final pricing are checked at checkout.
Product documentationFor laboratory research use only. Not for human consumption.
A closer look
The details
behind the compound.
Overview
GLP2-T is the house designation for a synthetic, acylated dual-agonist peptide of the incretin family — one engineered sequence that engages two receptor pathways at once: the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor.
Research interest centers on how a single molecule distributes activity across two related class-B receptors, and on how that balance reads against single-agonist reference peptides. It is offered strictly as a laboratory reference compound.
Laboratory documentation
A laboratory report is not available in the current product record for this format.
Research references
Finan B, et al. Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans. Sci Transl Med. 2013.
Capozzi ME, et al. Targeting the incretin/glucagon system with triagonists to treat diabetes. Endocr Rev. 2018.
Storage & handling
Store the lyophilized peptide at −20°C, desiccated and protected from light; −80°C for the longest terms. Reconstituted solution is aliquoted, held at 2–8°C, and used within a short window; avoid repeated freeze-thaw.
